Tirzepatide
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1871 publications
Genetic variants show link to patients losing more weight when taking Wegovy and Mounjaro.
Journal: BMJ (Clinical research ed.)
Published: April 13, 2026
Endocrinology: What You May Have Missed in 2025.
Journal: Annals of internal medicine
Published: April 13, 2026
Comparison of pharmacotherapies for obesity with sleeve gastrectomy: a network meta-analysis and systematic review.
Journal: Expert review of endocrinology & metabolism
Published: April 13, 2026
Tolerability and Effectiveness of Tirzepatide in Kidney Transplant Recipients: Real-world Experience From a Single-center Study.
Journal: Transplantation
Published: April 09, 2026
Tirzepatide-induced ketoacidosis with hyperglycemia in a patient without diabetes.
Journal: Archives of endocrinology and metabolism
Published: April 07, 2026
Drug-induced liver injury secondary to tirzepatide.
Journal: BMJ case reports
Published: April 03, 2026
Correction: Weight loss efficiency and safety of tirzepatide: A Systematic review.
Journal: PloS one
Published: April 02, 2026
Commentary on: "Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity".
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 31, 2026
Patient-Reported Outcomes in People With Type 2 Diabetes Escalating Dulaglutide or Switching From Dulaglutide to Tirzepatide.
Journal: Annals of internal medicine
Published: March 30, 2026
Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial.
Journal: JAMA cardiology
Published: March 28, 2026
Prevalence of Obesity Medications in the Military Health System: An Update from 2022.
Journal: Military medicine
Published: March 27, 2026
Last Updated: 04/28/2026